National Institute on Alcohol Abuse and Alcoholism; Notice of Meeting, 81833-81834 [2015-32941]
Download as PDF
Federal Register / Vol. 80, No. 251 / Thursday, December 31, 2015 / Notices
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Partnerships for the
Development of Novel Assays to Predict
Vaccine Efficacy.
Date: February 3–4, 2016.
Time: 12:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Room
3G61, 5601 Fishers Lane, Rockville, MD
20892 (Telephone Conference Call).
Contact Person: Brenda Lange-Gustafson,
Ph.D., Scientific Review Officer, NIAID/NIH/
DHHS, Scientific Review Program, 5601
Fishers Lane, Room 3G13, Rockville, MD
20852, 240–669–5047, bgustafson@
niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 23, 2015.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–32911 Filed 12–30–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
tkelley on DSK3SPTVN1PROD with NOTICES
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
VerDate Sep<11>2014
16:49 Dec 30, 2015
Jkt 238001
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Clinical Research on
Mind-Body Interventions.
Date: March 25, 2016.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott, 5701
Marinelli Road, Bethesda, MD 20817.
Contact Person: Hungyi Shau, Ph.D.,
Scientific Review Officer, National Center for
Complementary and Integrative Health,
National Institutes of Health, 6707
Democracy Boulevard, Suite 401, Bethesda,
MD 20892, 301–480–9504, Hungyi.Shau@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)
Dated: December 24, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–32909 Filed 12–30–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the meetings of the
National Advisory Council on Alcohol
Abuse and Alcoholism.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The open
sessions will be videocast and can be
accessed from the NIH Videocasting and
Podcasting Web site (https://
videocast.nih.gov).
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
81833
Name of Committee: National Advisory
Council on Alcohol Abuse and Alcoholism,
National Cancer Advisory Board, and
National Advisory Council on Drug Abuse
Open: February 11, 2016.
Time: 9:00 a.m. to 1:30 p.m.
Agenda: Presentation of NIAAA, NCI, and
NIDA Director’s Update, Scientific Reports,
and other topics within the scope of the
Collaborative Research on Addiction at NIH
(CRAN).
Place: National Institutes of Health,
Terrace Conference Rooms, 5635 Fishers
Lane, Rockville, MD 20892.
Contact: Abraham P. Bautista, Ph.D.,
Director, Office of Extramural Activities,
National Institute on Alcohol Abuse &
Alcoholism, National Institutes of Health,
5635 Fishers Lane, Room 2085, Rockville,
MD 20852, 301–443–9737, bautista@
mail.nih.gov.
Paulette S. Gray, Ph.D., Director, Division
of Extramural Activities, National Cancer
Institute, National Institutes of Health, 9609
Medical Center Drive, Room 7W444,
Bethesda, MD 20892, 240–276–6340, grayp@
dea.nci.nih.gov
Susan Weiss, Ph.D., Director, Division of
Extramural Research, National Institute on
Drug Abuse, National Institutes of Health,
6001 Executive Boulevard, NSC, Room 5274,
301–443–6487, sweiss@nida.nih.gov.
Name of Committee: National Advisory
Council on Alcohol Abuse and Alcoholism.
Closed: February 11, 2016.
Time: 2:15 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Terrace Conference Rooms, 5635 Fishers
Lane, Rockville, MD 20892.
Open: February 12, 2016.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: Presentations and other business
of the Council.
Place: National Institutes of Health,
Terrace Conference Rooms, 5635 Fishers
Lane, Rockville, MD 20892.
Contact Person: Abraham P. Bautista,
Ph.D., Executive Secretary, National Institute
on Alcohol Abuse & Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Room
2085, Rockville, MD 20852, 301–443–9737,
bautista@mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.niaaa.nih.gov/AboutNIAAA/
AdvisoryCouncil/Pages/default.aspx, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
E:\FR\FM\31DEN1.SGM
31DEN1
81834
Federal Register / Vol. 80, No. 251 / Thursday, December 31, 2015 / Notices
and Research Support Awards., National
Institutes of Health, HHS)
Dated: December 28, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–32941 Filed 12–30–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
tkelley on DSK3SPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant and contract
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant and contract applications, the
disclosure of which would constitute a
clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI SBIR
Targeted Radiation Therapy.
Date: January 27, 2016.
Time: 10:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate contract
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W538, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Ivan Ding, MD, Scientific
Review Officer, Special Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W412, Bethesda, MD 20892–
9750, 240–276–6444, dingi@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Physical
Sciences-Oncology Projects.
Date: February 9–10, 2016.
Time: 6:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree by Hilton Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Gerald G. Lovinger, Ph.D.,
Scientific Review Officer, Research and
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W266, Bethesda, MD 20892,
240–276–6385, lovingeg@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
I-Transition to Independence.
VerDate Sep<11>2014
16:49 Dec 30, 2015
Jkt 238001
Date: February 23–24, 2016.
Time: 8:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Tushar Baran Deb, Ph.D.,
Scientific Review Officer, Research and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W624, Rockville, MD 20850, 240–
276–6132 tushar.deb@nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Subcommittee
J—Career Development.
Date: March 2–3, 2016.
Time: 6:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, Suites 6711,
Democracy Boulevard, Bethesda, MD 20817.
Contact Person: Robert E. Bird, Ph.D.,
Scientific Review Officer, Research and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W110, Bethesda, MD 20892, 240–
276–6344, birdr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus R03 & R21 SEP–1.
Date: March 3–4, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree by Hilton Bethesda, 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Zhiqiang Zou, MD, Ph.D.,
Scientific Review Officer, Special Review
Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W242, Bethesda, MD
20892, 240–276–6372, zouzhiq@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Diagnosis.
Date: April 4–5, 2016.
Time: 8:30 a.m. to 12:00 p.m.
Agenda: To review and evaluate contract
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Bratin K. Saha, Ph.D.,
Program Coordination & Referral Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W556, Rockville, MD 20850,
240–276–6411, sahab@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Provocative Questions Review—PQ 12.
Date: April 6, 2016.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute, Shady
Grove, 9609 Medical Center Drive, Room
7W126, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Caron A. Lyman, Ph.D.,
Chief, Scientific Review Officer, Research
Program Review Branch, Division of
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W126, Bethesda, MD 20892–9750,
240–276–6348, lymanc@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: December 28, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–32935 Filed 12–30–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Drug
Abuse.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Drug Abuse.
Date: February 10, 2016.
Closed: 8:30 a.m. to 10:00 a.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Open: 10:30 a.m. to 4:00 p.m.
E:\FR\FM\31DEN1.SGM
31DEN1
Agencies
[Federal Register Volume 80, Number 251 (Thursday, December 31, 2015)]
[Notices]
[Pages 81833-81834]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32941]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism; Notice of
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the meetings of the
National Advisory Council on Alcohol Abuse and Alcoholism.
The meetings will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting. The open sessions will be
videocast and can be accessed from the NIH Videocasting and Podcasting
Web site (https://videocast.nih.gov).
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Alcohol Abuse
and Alcoholism, National Cancer Advisory Board, and National
Advisory Council on Drug Abuse
Open: February 11, 2016.
Time: 9:00 a.m. to 1:30 p.m.
Agenda: Presentation of NIAAA, NCI, and NIDA Director's Update,
Scientific Reports, and other topics within the scope of the
Collaborative Research on Addiction at NIH (CRAN).
Place: National Institutes of Health, Terrace Conference Rooms,
5635 Fishers Lane, Rockville, MD 20892.
Contact: Abraham P. Bautista, Ph.D., Director, Office of
Extramural Activities, National Institute on Alcohol Abuse &
Alcoholism, National Institutes of Health, 5635 Fishers Lane, Room
2085, Rockville, MD 20852, 301-443-9737, bautista@mail.nih.gov.
Paulette S. Gray, Ph.D., Director, Division of Extramural
Activities, National Cancer Institute, National Institutes of
Health, 9609 Medical Center Drive, Room 7W444, Bethesda, MD 20892,
240-276-6340, grayp@dea.nci.nih.gov
Susan Weiss, Ph.D., Director, Division of Extramural Research,
National Institute on Drug Abuse, National Institutes of Health,
6001 Executive Boulevard, NSC, Room 5274, 301-443-6487,
sweiss@nida.nih.gov.
Name of Committee: National Advisory Council on Alcohol Abuse
and Alcoholism.
Closed: February 11, 2016.
Time: 2:15 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Terrace Conference Rooms,
5635 Fishers Lane, Rockville, MD 20892.
Open: February 12, 2016.
Time: 9:00 a.m. to 2:00 p.m.
Agenda: Presentations and other business of the Council.
Place: National Institutes of Health, Terrace Conference Rooms,
5635 Fishers Lane, Rockville, MD 20892.
Contact Person: Abraham P. Bautista, Ph.D., Executive Secretary,
National Institute on Alcohol Abuse & Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Room 2085, Rockville, MD
20852, 301-443-9737, bautista@mail.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.niaaa.nih.gov/AboutNIAAA/AdvisoryCouncil/Pages/default.aspx, where an agenda and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.271,
Alcohol Research Career Development Awards for Scientists and
Clinicians; 93.272, Alcohol National Research Service Awards for
Research Training; 93.273, Alcohol Research Programs; 93.891,
Alcohol Research Center Grants; 93.701, ARRA Related Biomedical
Research
[[Page 81834]]
and Research Support Awards., National Institutes of Health, HHS)
Dated: December 28, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-32941 Filed 12-30-15; 8:45 am]
BILLING CODE 4140-01-P